PDE4 inhibitors (Aventis)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamePDE4 inhibitors (Aventis)

Drug Alias NamePDE4 inhibitors (Rhone-Poulenc Rorer)PDE4 inhibitors (RPR)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodieterase 4 inhibitors

TargetsPhosphodieterase 4

Therapy Area/IndicationsAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAventis Pharma

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAventis Pharma

Active IndicationsN/A

Inactive IndicationsAutoimmune Diseases

ATC CodeN/A